<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-36961" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Young's Rule</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Wade</surname>
            <given-names>Christian I.</given-names>
          </name>
          <aff>USUHS</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Martinez</surname>
            <given-names>Thirsa</given-names>
          </name>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Christian Wade declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Thirsa Martinez declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>8</day>
          <month>4</month>
          <year>2023</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-36961.s1" sec-type="Definition/Introduction">
        <title>Definition/Introduction</title>
        <p content-type="pubmed-excerpt">Young's Rule is an equation used to calculate pediatric medication dosage based on patient age and the known recommended adult dose. The definition of Young's Rule is the age of the patient divided by the age added to twelve, all multiplied by the recommended adult dose. This formula appears below:</p>
        <p>
<bold>[Age / (Age + 12)] x Recommended Adult Dose = Pediatric Dose</bold>
</p>
        <p>Young's Rule can be applied quickly in situations where the current weight of the patient is unknown. Other approaches to pediatric dosing&#x000a0;using age include the Webster and Fried rules.<xref ref-type="bibr" rid="article-36961.r1">[1]</xref></p>
        <p>The Clark Rule or the Body Surface Area&#x000a0;Rule can be implemented if the weight of the patient is known.<xref ref-type="bibr" rid="article-36961.r2">[2]</xref></p>
      </sec>
      <sec id="article-36961.s2" sec-type="Issues of Concern">
        <title>Issues of Concern</title>
        <p>Pediatric dosing based on age has the potential for suboptimal therapeutic levels due to the&#x000a0;broad range&#x000a0;of potential weight, especially with increasing childhood obesity. Young's Rule cannot be used for newborns, and consideration&#x000a0;must be&#x000a0;given to growth variability at the given age.<xref ref-type="bibr" rid="article-36961.r3">[3]</xref><xref ref-type="bibr" rid="article-36961.r4">[4]</xref>&#x000a0;Physiologically Based Pharmacokinetic (PBPK) models have been developed, which&#x000a0;can direct&#x000a0;drug dose selection in pediatric patients.<xref ref-type="bibr" rid="article-36961.r5">[5]</xref>&#x000a0;The Food and Drug Administration (FDA) endorses using PBPK modeling on a case-by-case basis.<xref ref-type="bibr" rid="article-36961.r6">[6]</xref>&#x000a0;However, these models rely on simulation and are more useful for the drug development process rather than routine clinical practice.<xref ref-type="bibr" rid="article-36961.r6">[6]</xref>&#x000a0;</p>
        <p>It should be noted that Young's Rule can be a guide for dosing but is not accurate for pediatric dose prediction. The activity&#x000a0;of&#x000a0;cytochrome P450 enzymes depends on age, leading to&#x000a0;high inter- and intra-individual variability in the pediatric population.<xref ref-type="bibr" rid="article-36961.r7">[7]</xref>&#x000a0;Consequently, therapeutic drug monitoring(TDM) should be considered for drugs with a narrow therapeutic index.<xref ref-type="bibr" rid="article-36961.r8">[8]</xref></p>
      </sec>
      <sec id="article-36961.s3" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>In situations&#x000a0;where the weight of the pediatric patient is unknown, for instance, at the point of injury, Young's Rule can be safely implemented if the patient age and the recommended adult dosing are known.&#x000a0;Age and the disease state can change the pharmacodynamics and&#x000a0;pharmacokinetics of the drug; consequently, an adjustment in the dosing regimen in children is necessary.<xref ref-type="bibr" rid="article-36961.r9">[9]</xref> Additionally, certain medications require weight-based dosings, such as antibiotics and antiepileptics. Ultimately, age-based dosing has been demonstrated to be a safe and effective approach. However, caution should be used depending on the class of the drug.&#x000a0;Young's Rule can be valuable when&#x000a0;there is limited information about pediatric dosing in the product labeling provided by&#x000a0;the manufacturer.<xref ref-type="bibr" rid="article-36961.r10">[10]</xref><xref ref-type="bibr" rid="article-36961.r11">[11]</xref></p>
      </sec>
      <sec id="article-36961.s4" sec-type="Nursing, Allied Health, and Interprofessional Team Interventions">
        <title>Nursing, Allied Health, and Interprofessional Team Interventions</title>
        <p>Knowledge of Young's Rule can serve several purposes in pediatric drug dosing, and interprofessional healthcare team members should be&#x000a0;familiar with it. The most obvious use is for the clinician when calculating the dose for a pediatric patient. A secondary use can be to verify that the dose ordered or prescribed is not outside of the parameters for the child. This is where nurses, during administration or pharmacists, when filling an order or prescription, can apply the&#x000a0;Young's Rule&#x000a0;and potentially prevent a toxic or therapeutically insufficient dose from being dispensed. In an open, interprofessional team environment, this can improve patient outcomes and prevent adverse events. [Level V]</p>
      </sec>
      <sec id="article-36961.s5">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=36961&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=36961">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/36961/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=36961">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-36961.s6">
        <title>References</title>
        <ref id="article-36961.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahmood</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>A comparison of different methods for the first-in-pediatric dose selection.</article-title>
            <source>J Clin Transl Res</source>
            <year>2022</year>
            <month>Oct</month>
            <day>31</day>
            <volume>8</volume>
            <issue>5</issue>
            <fpage>369</fpage>
            <page-range>369-381</page-range>
            <pub-id pub-id-type="pmid">36518546</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36961.r2">
          <label>2</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Delgado</surname>
                <given-names>BJ</given-names>
              </name>
              <name>
                <surname>Safadi</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Bajaj</surname>
                <given-names>T</given-names>
              </name>
            </person-group>
            <chapter-title>Clark's Rule</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2023</year>
            <month>7</month>
            <day>30</day>
            <pub-id pub-id-type="pmid">31082148</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36961.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Ogden</surname>
                <given-names>CL</given-names>
              </name>
              <name>
                <surname>Carroll</surname>
                <given-names>MD</given-names>
              </name>
              <name>
                <surname>Lawman</surname>
                <given-names>HG</given-names>
              </name>
              <name>
                <surname>Fryar</surname>
                <given-names>CD</given-names>
              </name>
              <name>
                <surname>Kruszon-Moran</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Kit</surname>
                <given-names>BK</given-names>
              </name>
              <name>
                <surname>Flegal</surname>
                <given-names>KM</given-names>
              </name>
            </person-group>
            <article-title>Trends in Obesity Prevalence Among Children and Adolescents in the United States, 1988-1994 Through 2013-2014.</article-title>
            <source>JAMA</source>
            <year>2016</year>
            <month>Jun</month>
            <day>07</day>
            <volume>315</volume>
            <issue>21</issue>
            <fpage>2292</fpage>
            <page-range>2292-9</page-range>
            <pub-id pub-id-type="pmid">27272581</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36961.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kendrick</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Carr</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Ensom</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Pharmacokinetics and drug dosing in obese children.</article-title>
            <source>J Pediatr Pharmacol Ther</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>15</volume>
            <issue>2</issue>
            <fpage>94</fpage>
            <page-range>94-109</page-range>
            <pub-id pub-id-type="pmid">22477800</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36961.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Jiang</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Wei</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Song</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Physiologically Based Pharmacokinetic Models Are Effective Support for Pediatric Drug Development.</article-title>
            <source>AAPS PharmSciTech</source>
            <year>2021</year>
            <month>Jul</month>
            <day>26</day>
            <volume>22</volume>
            <issue>6</issue>
            <fpage>208</fpage>
            <pub-id pub-id-type="pmid">34312742</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36961.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Jean</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Naik</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Milligan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Hall</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Mei Huang</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Isoherranen</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Kuemmel</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Seo</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Tegenge</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Benjamin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Bergman</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Grillo</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Madabushi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wu</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Zhu</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Zineh</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Development of best practices in physiologically based pharmacokinetic modeling to support clinical pharmacology regulatory decision-making-A workshop summary.</article-title>
            <source>CPT Pharmacometrics Syst Pharmacol</source>
            <year>2021</year>
            <month>Nov</month>
            <volume>10</volume>
            <issue>11</issue>
            <fpage>1271</fpage>
            <page-range>1271-1275</page-range>
            <pub-id pub-id-type="pmid">34536337</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36961.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Magliocco</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rodieux</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Desmeules</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Samer</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Daali</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Toward precision medicine in pediatric population using cytochrome P450 phenotyping approaches and physiologically based pharmacokinetic modeling.</article-title>
            <source>Pediatr Res</source>
            <year>2020</year>
            <month>Feb</month>
            <volume>87</volume>
            <issue>3</issue>
            <fpage>441</fpage>
            <page-range>441-449</page-range>
            <pub-id pub-id-type="pmid">31600772</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36961.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Simeoli</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Dorlo</surname>
                <given-names>TPC</given-names>
              </name>
              <name>
                <surname>Hanff</surname>
                <given-names>LM</given-names>
              </name>
              <name>
                <surname>Huitema</surname>
                <given-names>ADR</given-names>
              </name>
              <name>
                <surname>Dreesen</surname>
                <given-names>E</given-names>
              </name>
            </person-group>
            <article-title>Editorial: Therapeutic Drug Monitoring (TDM): A Useful Tool for Pediatric Pharmacology Applied to Routine Clinical Practice.</article-title>
            <source>Front Pharmacol</source>
            <year>2022</year>
            <volume>13</volume>
            <fpage>931843</fpage>
            <pub-id pub-id-type="pmid">35685621</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36961.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mahmood</surname>
                <given-names>I</given-names>
              </name>
            </person-group>
            <article-title>Dosing in children: a critical review of the pharmacokinetic allometric scaling and modelling approaches in paediatric drug development and clinical settings.</article-title>
            <source>Clin Pharmacokinet</source>
            <year>2014</year>
            <month>Apr</month>
            <volume>53</volume>
            <issue>4</issue>
            <fpage>327</fpage>
            <page-range>327-46</page-range>
            <pub-id pub-id-type="pmid">24515100</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36961.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Elias</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Antoniali</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mariano</surname>
                <given-names>RC</given-names>
              </name>
            </person-group>
            <article-title>Comparative study of rules employed for calculation of pediatric drug dosage.</article-title>
            <source>J Appl Oral Sci</source>
            <year>2005</year>
            <month>Jun</month>
            <volume>13</volume>
            <issue>2</issue>
            <fpage>114</fpage>
            <page-range>114-9</page-range>
            <pub-id pub-id-type="pmid">20924533</pub-id>
          </element-citation>
        </ref>
        <ref id="article-36961.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kendrick</surname>
                <given-names>JG</given-names>
              </name>
              <name>
                <surname>Carr</surname>
                <given-names>RR</given-names>
              </name>
              <name>
                <surname>Ensom</surname>
                <given-names>MH</given-names>
              </name>
            </person-group>
            <article-title>Pediatric Obesity: Pharmacokinetics and Implications for Drug Dosing.</article-title>
            <source>Clin Ther</source>
            <year>2015</year>
            <month>Sep</month>
            <day>01</day>
            <volume>37</volume>
            <issue>9</issue>
            <fpage>1897</fpage>
            <page-range>1897-923</page-range>
            <pub-id pub-id-type="pmid">26361823</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
